Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial.

ABSTRACT:

SUBMITTER: Aman J 

PROVIDER: S-EPMC8232929 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature